Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.

Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T.

Circ Res. 2003 Sep 5;93(5):438-47. Epub 2003 Jul 24.


Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M, Ferrara N.

Cancer Res. 1997 Oct 15;57(20):4593-9.


Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8.

Schruefer R, Lutze N, Schymeinsky J, Walzog B.

Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1186-92. Epub 2004 Oct 21.


Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand.

Min JK, Kim YM, Kim YM, Kim EC, Gho YS, Kang IJ, Lee SY, Kong YY, Kwon YG.

J Biol Chem. 2003 Oct 10;278(41):39548-57. Epub 2003 Jul 31.


Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells.

Fan F, Stoeltzing O, Liu W, McCarty MF, Jung YD, Reinmuth N, Ellis LM.

Cancer Res. 2004 May 1;64(9):3186-90.


Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.

Tamura K, Hashimoto K, Suzuki K, Yoshie M, Kutsukake M, Sakurai T.

Eur J Pharmacol. 2009 May 21;610(1-3):61-7. doi: 10.1016/j.ejphar.2009.01.045. Epub 2009 Feb 5.


Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans.

Mordenti J, Thomsen K, Licko V, Chen H, Meng YG, Ferrara N.

Toxicol Pathol. 1999 Jan-Feb;27(1):14-21.


Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.

Lin YS, Nguyen C, Mendoza JL, Escandon E, Fei D, Meng YG, Modi NB.

J Pharmacol Exp Ther. 1999 Jan;288(1):371-8.


Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells.

Salcedo R, Zhang X, Young HA, Michael N, Wasserman K, Ma WH, Martins-Green M, Murphy WJ, Oppenheim JJ.

Blood. 2003 Sep 15;102(6):1966-77. Epub 2003 Jun 5.


Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N.

Arthritis Rheum. 2003 Jun;48(6):1521-9.


Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.

Sun J, Blaskovich MA, Jain RK, Delarue F, Paris D, Brem S, Wotoczek-Obadia M, Lin Q, Coppola D, Choi K, Mullan M, Hamilton AD, Sebti SM.

Cancer Res. 2004 May 15;64(10):3586-92.


Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.

Ma X, Ottino P, Bazan HE, Bazan NG.

Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2915-21.


Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha.

Stannard AK, Khurana R, Evans IM, Sofra V, Holmes DI, Zachary I.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):494-502. Epub 2006 Dec 14.


Stretch induces upregulation of key tyrosine kinase receptors in microvascular endothelial cells.

Zheng W, Christensen LP, Tomanek RJ.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2739-45.


VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.

Onimaru M, Yonemitsu Y, Fujii T, Tanii M, Nakano T, Nakagawa K, Kohno R, Hasegawa M, Nishikawa S, Sueishi K.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1685-96. doi: 10.1152/ajpheart.00015.2009. Epub 2009 Sep 4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk